Connecting Patients With Specialty Products: Distribution models for biologics and other specialty pharmaceutical products, an article in the latest Biotechnology Healthcare journal.
Jack McCain, the reporter at BH, did a super job of boiling down the complex specialty distribution market into a succinct summary of current trends and product models.
See below for a chart illustrating the complexity of specialty drugs’ product flow under the pharmacy benefit. I helped out with the article, so you'll see some quotes from me, along with comments from consultants such as Elan Rubinstein and Ron Krawczyk.
Part 2, focusing on emerging trends, will appear later this year.
Would you believe ... this is how specialty drugs flow to patients?